BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Meining A, Morgner A, Miehlke S, Bayerdörffer E, Stolte M. Atrophy–metaplasia–dysplasia–carcinoma sequence in the stomach: a reality or merely an hypothesis? Best Practice & Research Clinical Gastroenterology 2001;15:983-98. [DOI: 10.1053/bega.2001.0253] [Cited by in Crossref: 67] [Cited by in F6Publishing: 53] [Article Influence: 3.4] [Reference Citation Analysis]
Number Citing Articles
1 Shiotani A, Cen P, Graham DY. Eradication of gastric cancer is now both possible and practical. Semin Cancer Biol. 2013;23:492-501. [PMID: 23876852 DOI: 10.1016/j.semcancer.2013.07.004] [Cited by in Crossref: 57] [Cited by in F6Publishing: 54] [Article Influence: 7.1] [Reference Citation Analysis]
2 Hwang YJ, Kim N, Lee HS, Lee JB, Choi YJ, Yoon H, Shin CM, Park YS, Lee DH. Reversibility of atrophic gastritis and intestinal metaplasia after Helicobacter pylori eradication - a prospective study for up to 10 years. Aliment Pharmacol Ther. 2018;47:380-390. [PMID: 29193217 DOI: 10.1111/apt.14424] [Cited by in Crossref: 74] [Cited by in F6Publishing: 50] [Article Influence: 18.5] [Reference Citation Analysis]
3 Tulassay Z, Stolte M, Engstrand L, Butruk E, Malfertheiner P, Dítê P, Tchernev K, Wong BC, Gottlow M, Eklund S, Wrangstadh M, Herszényi L, Nagy P; HELIX Study Investigators. Twelve-month endoscopic and histological analysis following proton-pump inhibitor-based triple therapy in Helicobacter pylori-positive patients with gastric ulcers. Scand J Gastroenterol 2010;45:1048-58. [PMID: 20509752 DOI: 10.3109/00365520903575737] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
4 Kim N, Park YS, Cho SI, Lee HS, Choe G, Kim IW, Won YD, Park JH, Kim JS, Jung HC, Song IS. Prevalence and risk factors of atrophic gastritis and intestinal metaplasia in a Korean population without significant gastroduodenal disease. Helicobacter. 2008;13:245-255. [PMID: 18665932 DOI: 10.1111/j.1523-5378.2008.00604.x] [Cited by in Crossref: 85] [Cited by in F6Publishing: 65] [Article Influence: 6.5] [Reference Citation Analysis]
5 Shiotani A, Uedo N, Iishi H, Tatsuta M, Ishiguro S, Nakae Y, Kamada T, Haruma K, Merchant JL. Re-expression of sonic hedgehog and reduction of CDX2 after Helicobacter pylori eradication prior to incomplete intestinal metaplasia. Int J Cancer. 2007;121:1182-1189. [PMID: 17520681 DOI: 10.1002/ijc.22835] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 1.8] [Reference Citation Analysis]
6 Peitz U, Kouznetsova I, Wex T, Gebert I, Vieth M, Roessner A, Hoffmann W, Malfertheiner P. TFF3 expression at the esophagogastric junction is increased in gastro-esophageal reflux disease (GERD). Peptides. 2004;25:771-777. [PMID: 15177871 DOI: 10.1016/j.peptides.2004.01.018] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
7 Wang KX, Wang XF, Peng JL, Cui YB, Wang J, Li CP. Detection of serum anti-Helicobacter pylori immunoglobulin G in patients with different digestive malignant tumors. World J Gastroenterol 2003;9:2501-4. [PMID: 14606084 DOI: 10.3748/wjg.v9.i11.2501] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
8 Choi S, Lim YJ, Park SK. Risk factor analysis for metaplastic gastritis in Koreans. World J Gastroenterol 2006;12:2584-7. [PMID: 16688806 DOI: 10.3748/wjg.v12.i16.2584] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
9 Lee HJ, Nam KT, Park HS, Kim MA, Lafleur BJ, Aburatani H, Yang HK, Kim WH, Goldenring JR. Gene expression profiling of metaplastic lineages identifies CDH17 as a prognostic marker in early stage gastric cancer. Gastroenterology. 2010;139:213-25.e3. [PMID: 20398667 DOI: 10.1053/j.gastro.2010.04.008] [Cited by in Crossref: 88] [Cited by in F6Publishing: 85] [Article Influence: 8.0] [Reference Citation Analysis]
10 Bir F, Calli-Demirkan N, Tufan AC, Akbulut M, Satiroglu-Tufan NL. Apoptotic cell death and its relationship to gastric carcinogenesis. World J Gastroenterol 2007;13:3183-8. [PMID: 17589896 DOI: 10.3748/wjg.v13.i23.3183] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
11 McLoughlin JM. Adenocarcinoma of the stomach: a review. Proc (Bayl Univ Med Cent) 2004;17:391-9. [PMID: 16200126 DOI: 10.1080/08998280.2004.11928001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
12 Petersen CP, Weis VG, Nam KT, Sousa JF, Fingleton B, Goldenring JR. Macrophages promote progression of spasmolytic polypeptide-expressing metaplasia after acute loss of parietal cells. Gastroenterology. 2014;146:1727-38.e8. [PMID: 24534633 DOI: 10.1053/j.gastro.2014.02.007] [Cited by in Crossref: 62] [Cited by in F6Publishing: 54] [Article Influence: 8.9] [Reference Citation Analysis]
13 Nam KT, O’Neal RL, Coffey RJ, Finke PE, Barker N, Goldenring JR. Spasmolytic polypeptide-expressing metaplasia (SPEM) in the gastric oxyntic mucosa does not arise from Lgr5-expressing cells. Gut. 2012;61:1678-1685. [PMID: 22198711 DOI: 10.1136/gutjnl-2011-301193] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 3.5] [Reference Citation Analysis]
14 Lahner E, Carabotti M, Annibale B. Treatment of Helicobacter pylori infection in atrophic gastritis. World J Gastroenterol. 2018;24:2373-2380. [PMID: 29904244 DOI: 10.3748/wjg.v24.i22.2373] [Cited by in CrossRef: 20] [Cited by in F6Publishing: 13] [Article Influence: 6.7] [Reference Citation Analysis]
15 Lahner E, Bernardini G, Santucci A, Annibale B. Helicobacter pylori immunoproteomics in gastric cancer and gastritis of the carcinoma phenotype. Expert Rev Proteomics. 2010;7:239-248. [PMID: 20377390 DOI: 10.1586/epr.10.5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
16 Liu Q, Teh M, Ito K, Shah N, Ito Y, Yeoh KG. CDX2 expression is progressively decreased in human gastric intestinal metaplasia, dysplasia and cancer. Mod Pathol. 2007;20:1286-1297. [PMID: 17906616 DOI: 10.1038/modpathol.3800968] [Cited by in Crossref: 62] [Cited by in F6Publishing: 55] [Article Influence: 4.4] [Reference Citation Analysis]
17 Rigoli L, Caruso RA. Mitochondrial DNA alterations in the progression of gastric carcinomas: unexplored issues and future research needs. World J Gastroenterol 2014;20:16159-66. [PMID: 25473169 DOI: 10.3748/wjg.v20.i43.16159] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
18 Lahner E, Esposito G, Pilozzi E, Purchiaroni F, Corleto VD, Di Giulio E, Annibale B. Occurrence of gastric cancer and carcinoids in atrophic gastritis during prospective long-term follow up. Scand J Gastroenterol 2015;50:856-65. [PMID: 25645880 DOI: 10.3109/00365521.2015.1010570] [Cited by in Crossref: 43] [Cited by in F6Publishing: 38] [Article Influence: 7.2] [Reference Citation Analysis]
19 Uchida M, Tsukamoto Y, Uchida T, Ishikawa Y, Nagai T, Hijiya N, Nguyen LT, Nakada C, Kuroda A, Okimoto T. Genomic profiling of gastric carcinoma in situ and adenomas by array-based comparative genomic hybridization. J Pathol. 2010;221:96-105. [PMID: 20217874 DOI: 10.1002/path.2686] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 1.8] [Reference Citation Analysis]
20 Farinati F, Cardin R, Russo VM, Busatto G, Franco M, Rugge M. Helicobacter pylori CagA status, mucosal oxidative damage and gastritis phenotype: a potential pathway to cancer? Helicobacter. 2003;8:227-234. [PMID: 12752735 DOI: 10.1046/j.1523-5378.2003.00149.x] [Cited by in Crossref: 48] [Cited by in F6Publishing: 42] [Article Influence: 2.7] [Reference Citation Analysis]
21 Leung WK, Ng EKW, Lam CCH, Chan K, Chan WY, Auyeung ACM, Wu JCY, Ching JYL, Lau JYW, Sung JJY. Helicobacter pylori infection in 1st degree relatives of Chinese gastric cancer patients. Scandinavian Journal of Gastroenterology 2009;41:274-9. [DOI: 10.1080/00365520510024269] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
22 Lahner E, Hassan C, Esposito G, Carabotti M, Zullo A, Dinis-ribeiro M, Annibale B. Cost of detecting gastric neoplasia by surveillance endoscopy in atrophic gastritis in Italy: A low risk country. Digestive and Liver Disease 2017;49:291-6. [DOI: 10.1016/j.dld.2016.12.004] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
23 Friis-Hansen L, Rieneck K, Nilsson HO, Wadström T, Rehfeld JF. Gastric inflammation, metaplasia, and tumor development in gastrin-deficient mice. Gastroenterology. 2006;131:246-258. [PMID: 16831607 DOI: 10.1053/j.gastro.2006.04.031] [Cited by in Crossref: 40] [Cited by in F6Publishing: 42] [Article Influence: 2.7] [Reference Citation Analysis]
24 Gruno M, Peet N, Seppet E, Kadaja L, Paju K, Eimre M, Orlova E, Peetsalu M, Tein A, Soplepmann J. Oxidative phosphorylation and its coupling to mitochondrial creatine and adenylate kinases in human gastric mucosa. Am J Physiol Regul Integr Comp Physiol. 2006;291:R936-R946. [PMID: 16741143 DOI: 10.1152/ajpregu.00162.2006] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
25 Oh JH, Rhyu MG, Kim SI, Yun MR, Shin JH, Hong SJ. Gastric Mucosal Atrophy Impedes Housekeeping Gene Methylation in Gastric Cancer Patients. Cancer Res Treat 2019;51:267-79. [PMID: 29747491 DOI: 10.4143/crt.2018.085] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
26 van Grieken NC, Meijer GA, zur Hausen A, Meuwissen SG, Baak JP, Kuipers EJ. Increased apoptosis in gastric mucosa adjacent to intestinal metaplasia. J Clin Pathol. 2003;56:358-361. [PMID: 12719456 DOI: 10.1136/jcp.56.5.358] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 0.7] [Reference Citation Analysis]
27 Graham DY, Shiotani A. The time to eradicate gastric cancer is now. Gut. 2005;54:735-738. [PMID: 15888771 DOI: 10.1136/gut.2004.056549] [Cited by in Crossref: 85] [Cited by in F6Publishing: 78] [Article Influence: 5.3] [Reference Citation Analysis]
28 Park YH, Kim N. Review of atrophic gastritis and intestinal metaplasia as a premalignant lesion of gastric cancer. J Cancer Prev. 2015;20:25-40. [PMID: 25853101 DOI: 10.15430/jcp.2015.20.1.25] [Cited by in Crossref: 124] [Cited by in F6Publishing: 57] [Article Influence: 20.7] [Reference Citation Analysis]
29 Rhyu MG, Oh JH, Kim TH, Kim JS, Rhyu YA, Hong SJ. Periodic Fluctuations in the Incidence of Gastrointestinal Cancer. Front Oncol 2021;11:558040. [PMID: 33833981 DOI: 10.3389/fonc.2021.558040] [Reference Citation Analysis]
30 Friis-hansen L. Lessons from the gastrin knockout mice. Regulatory Peptides 2007;139:5-22. [DOI: 10.1016/j.regpep.2006.12.008] [Cited by in Crossref: 24] [Cited by in F6Publishing: 14] [Article Influence: 1.7] [Reference Citation Analysis]
31 Trautmann K, Stolte M, Miehlke S. Eradication of H pylori for the prevention of gastric cancer. World J Gastroenterol 2006;12:5101-7. [PMID: 16937519 DOI: 10.3748/wjg.v12.i32.5101] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
32 de Vries AC, Haringsma J, Kuipers EJ. The Detection, Surveillance and Treatment of Premalignant Gastric Lesions Related to Helicobacter pylori Infection. Helicobacter 2007;12. [DOI: 10.1111/j.1523-5378.2007.00475.x] [Cited by in Crossref: 65] [Cited by in F6Publishing: 58] [Article Influence: 4.6] [Reference Citation Analysis]
33 Shiotani A, Iishi H, Uedo N, Ishiguro S, Tatsuta M, Nakae Y, Kumamoto M, Merchant JL. Evidence that loss of sonic hedgehog is an indicator of Helicobater pylori-induced atrophic gastritis progressing to gastric cancer. Am J Gastroenterol. 2005;100:581-587. [PMID: 15743355 DOI: 10.1111/j.1572-0241.2005.41001.x] [Cited by in Crossref: 68] [Cited by in F6Publishing: 63] [Article Influence: 4.3] [Reference Citation Analysis]
34 Hohenberger P, Gretschel S. Gastric cancer. Lancet. 2003;362:305-315. [PMID: 12892963 DOI: 10.1016/s0140-6736(03)13975-x] [Cited by in Crossref: 430] [Cited by in F6Publishing: 203] [Article Influence: 23.9] [Reference Citation Analysis]
35 Shiotani A, Iishi H, Uedo N, Ishihara R, Ishiguro S, Tatsuta M, Nakae Y, Kumamoto M, Hinoi T, Merchant JL. Helicobacter pylori-induced atrophic gastritis progressing to gastric cancer exhibits sonic hedgehog loss and aberrant CDX2 expression. Aliment Pharmacol Ther. 2006;24 Suppl 4:71-80. [PMID: 17209848 DOI: 10.1111/j.1365-2036.2006.00028.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 11] [Article Influence: 0.5] [Reference Citation Analysis]
36 Glas J, Török HP, Schneider A, Brünnler G, Kopp R, Albert ED, Stolte M, Folwaczny C. Allele 2 of the interleukin-1 receptor antagonist gene is associated with early gastric cancer. J Clin Oncol. 2004;22:4746-4752. [PMID: 15570075 DOI: 10.1200/jco.2004.03.034] [Cited by in Crossref: 38] [Cited by in F6Publishing: 23] [Article Influence: 2.4] [Reference Citation Analysis]
37 Polydorides AD. Pathology and differential diagnosis of chronic, noninfectious gastritis. Seminars in Diagnostic Pathology 2014;31:114-23. [DOI: 10.1053/j.semdp.2014.02.008] [Cited by in Crossref: 14] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
38 Rodrigues MF, Guerra MR, Alvarenga AVR, Souza DZO, Costa RAVES, Cupolilo SMN. HELICOBACTER PYLORI INFECTION AND GASTRIC CANCER PRECURSOR LESIONS: PREVALENCE AND ASSOCIATED FACTORS IN A REFERENCE LABORATORY IN SOUTHEASTERN BRAZIL. Arq Gastroenterol 2019;56:419-24. [PMID: 31800739 DOI: 10.1590/S0004-2803.201900000-84] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
39 Hu X, Sui X, Li L, Huang X, Rong R, Su X, Shi Q, Mo L, Shu X, Kuang Y, Tao Q, He C. Protocadherin 17 acts as a tumour suppressor inducing tumour cell apoptosis and autophagy, and is frequently methylated in gastric and colorectal cancers. J Pathol. 2013;229:62-73. [PMID: 22926751 DOI: 10.1002/path.4093] [Cited by in Crossref: 67] [Cited by in F6Publishing: 65] [Article Influence: 8.4] [Reference Citation Analysis]
40 Kim N, Park RY, Cho SI, Lim SH, Lee KH, Lee W, Kang HM, Lee HS, Jung HC, Song IS. Helicobacter pylori infection and development of gastric cancer in Korea: long-term follow-up. J Clin Gastroenterol. 2008;42:448-454. [PMID: 18344895 DOI: 10.1097/mcg.0b013e318046eac3] [Cited by in Crossref: 82] [Cited by in F6Publishing: 41] [Article Influence: 6.3] [Reference Citation Analysis]
41 Riquelme I, Saavedra K, Espinoza JA, Weber H, García P, Nervi B, Garrido M, Corvalán AH, Roa JC, Bizama C. Molecular classification of gastric cancer: Towards a pathway-driven targeted therapy. Oncotarget 2015;6:24750-79. [PMID: 26267324 DOI: 10.18632/oncotarget.4990] [Cited by in Crossref: 78] [Cited by in F6Publishing: 66] [Article Influence: 15.6] [Reference Citation Analysis]
42 Friis‐hansen L. Achlorhydria is associated with gastric microbial overgrowth and development of cancer: Lessons learned from the gastrin knockout mouse. Scandinavian Journal of Clinical and Laboratory Investigation 2009;66:607-22. [DOI: 10.1080/00365510600873894] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 2.1] [Reference Citation Analysis]
43 Shiotani A, Haruma K, Uedo N, Iishi H, Ishihara R, Tatsuta M, Kumamoto M, Nakae Y, Ishiguro S, Graham DY. Histological risk markers for non-cardia early gastric cancer. Pattern of mucin expression and gastric cancer. Virchows Arch. 2006;449:652-659. [PMID: 17058096 DOI: 10.1007/s00428-006-0300-8] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
44 Leja M, Wex T, Malfertheiner P. Markers for gastric cancer premalignant lesions: where do we go? Dig Dis. 2012;30:268-276. [PMID: 22722551 DOI: 10.1159/000336990] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 2.1] [Reference Citation Analysis]
45 Shiotani A, Iishi H, Uedo N, Kumamoto M, Nakae Y, Ishiguro S, Tatsuta M, Graham DY. Histologic and serum risk markers for noncardia early gastric cancer. Int J Cancer. 2005;115:463-469. [PMID: 15688378 DOI: 10.1002/ijc.20852] [Cited by in Crossref: 53] [Cited by in F6Publishing: 51] [Article Influence: 3.3] [Reference Citation Analysis]
46 Nomura S, Settle SH, Leys CM, Means AL, Peek RM Jr, Leach SD, Wright CV, Coffey RJ, Goldenring JR. Evidence for repatterning of the gastric fundic epithelium associated with Ménétrier's disease and TGFalpha overexpression. Gastroenterology 2005;128:1292-305. [PMID: 15887112 DOI: 10.1053/j.gastro.2005.03.019] [Cited by in Crossref: 50] [Cited by in F6Publishing: 48] [Article Influence: 3.1] [Reference Citation Analysis]
47 Shiotani A, Iishi H, Uedo N, Ishihara R, Ishiguro S, Tatsuta M, Nakae Y, Kumamoto M, Hinoi T, Merchant JL. Helicobacter pylori-induced atrophic gastritis progressing to gastric cancer exhibits sonic hedgehog loss and aberrant CDX2 expression. Aliment Pharmacol Ther Symp Series 2006;2:71-80. [DOI: 10.1111/j.1746-6342.2006.00028.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
48 Mahdavi J, Borén T, Vandenbroucke-Grauls C, Appelmelk BJ. Limited role of lipopolysaccharide Lewis antigens in adherence of Helicobacter pylori to the human gastric epithelium. Infect Immun 2003;71:2876-80. [PMID: 12704161 DOI: 10.1128/IAI.71.5.2876-2880.2003] [Cited by in Crossref: 29] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
49 Ouburg S, Bart A. Crusius J, Klinkenberg-knol EC, Mulder CJ, Salvador Pe??a A, Morr?? SA. A candidate gene approach of immune mediators effecting the susceptibility to and severity of upper gastrointestinal tract diseases in relation to Helicobacter pylori and Epstein???Barr virus infections: . European Journal of Gastroenterology & Hepatology 2005;17:1213-24. [DOI: 10.1097/00042737-200511000-00010] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
50 Oh JH, Jung SH, Hong SJ, Rhyu MG. DNA Methylation as Surrogate Marker For Gastric Cancer. J Cancer Prev 2015;20:172-8. [PMID: 26473155 DOI: 10.15430/JCP.2015.20.3.172] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
51 Calcagno DQ, Leal MF, Demachki S, Araújo MT, Freitas FW, Oliveira e Souza D, Assumpção PP, Ishak G, de Arruda Cardoso Smith M, Burbano RR. MYC in gastric carcinoma and intestinal metaplasia of young adults. Cancer Genet Cytogenet 2010;202:63-6. [PMID: 20804924 DOI: 10.1016/j.cancergencyto.2010.05.020] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 2.0] [Reference Citation Analysis]
52 Rhyu MG, Oh JH, Hong SJ. Species-specific role of gene-adjacent retroelements in human and mouse gastric carcinogenesis. Int J Cancer 2018;142:1520-7. [PMID: 29055047 DOI: 10.1002/ijc.31120] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
53 Malfertheiner P. Gastric Atrophy Reversible or Irreversible after <i>Helicobacter pylori</i> Eradication – An Open Question. Digestion 2011;83:250-2. [DOI: 10.1159/000321529] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]